Furthermore, the reduced appetite caused by GLP-1 therapy can make it harder to get all your essential vitamins through food alone
Chronic low-grade inflammation underlies cardiovascular disease, fatty liver disease, insulin resistance, joint degeneration, cognitive decline, and cancer risk
The compounds improve hepatic and visceral fat clearance preferentially because those stores have higher metabolic turnover, but subcutaneous fat loss follows general body composition patterns determined by genetics, not injection site
"Retatrutide, a novel triple GIP/GLP-1/glucagon receptor agonist, improves metabolic parameters in obese adults." Cell Metab
Start Your 14-Day Risk-Free Trial When to Contact Your Healthcare Provider While mild changes in appetite or digestion can be expected for some people taking GLP-1 medications, it's important to contact your healthcare provider if you experience persistent vomiting, severe diarrhea, ongoing dizziness, signs of dehydration, or if you're concerned about your ability to stay hydrated
Lyophilization removes water from the peptide under carefully controlled conditions, producing a dry powder that is considerably more stable during manufacturing, shipping, and long-term storage than an already dissolved solution
